Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Cash from Financing Activities (2023 - 2025)

Historic Cash from Financing Activities for SANUWAVE Health (SNWV) over the last 9 years, with Q3 2025 value amounting to -$4.4 million.

  • SANUWAVE Health's Cash from Financing Activities fell 92298.85% to -$4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 2252.3%. This contributed to the annual value of $6.4 million for FY2024, which is 2193.44% up from last year.
  • As of Q3 2025, SANUWAVE Health's Cash from Financing Activities stood at -$4.4 million, which was down 92298.85% from $161000.0 recorded in Q2 2025.
  • SANUWAVE Health's Cash from Financing Activities' 5-year high stood at $6.5 million during Q4 2024, with a 5-year trough of -$4.4 million in Q3 2025.
  • In the last 3 years, SANUWAVE Health's Cash from Financing Activities had a median value of $161000.0 in 2025 and averaged $656272.7.
  • As far as peak fluctuations go, SANUWAVE Health's Cash from Financing Activities soared by 24894.88% in 2024, and later crashed by 92298.85% in 2025.
  • Over the past 3 years, SANUWAVE Health's Cash from Financing Activities (Quarter) stood at $1.9 million in 2023, then surged by 248.95% to $6.5 million in 2024, then plummeted by 168.75% to -$4.4 million in 2025.
  • Its last three reported values are -$4.4 million in Q3 2025, $161000.0 for Q2 2025, and -$57000.0 during Q1 2025.